AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Zealand Pharma

Director's Dealing Dec 25, 2024

3391_rpt_2024-12-25_3e715006-cd7f-4222-bc13-2bd25a9ae0ec.pdf

Director's Dealing

Open in Viewer

Opens in native device viewer

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1. Details of the person discharging managerial responsibilities/person closely associated
a) Name Leonard Kruimer
2 Reason for the notification
a) Position/status Member of the Board of Directors of Zealand Pharma A/S
b) Initial notification/Amend-
ment
Initial notification
3. tion monitor Details of the issuer, emission allowance market participant, auctioneer or auctioneer or auc-
a) Name Zealand Pharma A/S
d) I Fi 549300ITBB1ULBL4CZ12
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type
of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial
instrument, type of instru-
ment
Ordinary shares.
Identification code DK0060257814
d) Nature of the transaction Purchase of shares.
C) Price(s) and volume(s) Price(s) Volume(s)
DKK 720 300
d) Aggregated information
Aggregated volume 300
Price DKK 216,000
e) Date of the transaction 2024-12-20
Place of the transaction Nasdaq Copenhagen A/S, XCSE

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1. Details of the person discharging managerial responsibilities/person closely associated
a) Name Leonard Kruimer
2 Reason for the notification
a) Position/status Member of the Board of Directors of Zealand Pharma A/S
b) Initial notification/Amend-
ment
Initial notification
3. tion monitor Details of the issuer, emission allowance market participant, auctioneer or auctioneer or auc-
a) Name Zealand Pharma A/S
b) LEI 549300ITBB1ULBL4CZ12
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type
of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial
instrument, type of instru-
ment
Ordinary shares.
Identification code DK0060257814
d) Nature of the transaction Purchase of shares.
C) Price(s) and volume(s) Price(s) Volume(s)
DKK 660 31
d) Aggregated information
Aggregated volume 31
Price DKK 20,460
e) Date of the transaction 2024-12-21
f) Place of the transaction Nasdaq Copenhagen A/S, XCSE

Talk to a Data Expert

Have a question? We'll get back to you promptly.